Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Disappearing MS T2 lesions may have persistent tissue injury by diffusion tensor and magnetisation transfer imaging
Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach.
Switching from natalizumab to fingolimod: an observational study.
Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells.
MRI in multiple sclerosis: what's inside the toolbox?
Letter to the Editor: Trigeminal neuralgia in patients with multiple sclerosis.
OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS.
An Electrophoretic Study of the Protein Components in Cerebrospinal Fluid and their Relationship to the Serum Proteins.
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis.
Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells.
Is progressive multiple sclerosis a gray matter disease?
The effectiveness of a self-management occupational therapy intervention on activity performance in individuals with multiple sclerosis-related fatigue: a randomized-controlled trial.
Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?
Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.
MRI monitoring of spinal cord changes in patients with multiple sclerosis.
Disability as an outcome in MS clinical trials.
Multiple sclerosis: Real-world long-term benefits of disease-modifying MS therapy.
MR imaging intensity modeling of damage and repair in multiple sclerosis: relationship of short-term lesion recovery to progression and disability.
Treating multiple sclerosis with monoclonal antibodies: a 2010 update.
Estrogens, Neuroinflammation and Neurodegeneration.
Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment.
Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists' Perspectives.
Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study.
Manual Segmentation of MS Cortical Lesions Using MRI: A Comparison of 3 MRI Reading Protocols.
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »